General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Why Is AIkido Pharma (AIKI) Stock Up 1,400%? | investorplace.com • |
Aikido Pharma (AIKI) Stock Price: 1-For-17 Reverse Split Goes Into Effect | pulse2.com • |
Trending Penny Stocks to Watch After Holiday Season | pennystocks.com • |
5 Top Penny Stocks To Watch Under $1 After CSCW Stock Explodes | pennystocks.com • |
Best Penny Stocks to Buy Right Now? 3 to Watch This Month | pennystocks.com • |
Best Penny Stocks to Buy in November? 3 You Need to Know About | pennystocks.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2022-11-10 | 2022-09 | -0.77 | N/A | N/A | N/A |
2022-08-12 | 2022-06 | -0.68 | N/A | N/A | N/A |
2022-05-16 | 2022-03 | -0.34 | N/A | N/A | N/A |
2022-03-28 | 2021-12 | 0 | N/A | N/A | N/A |
2021-11-10 | 2021-09 | -0.51 | N/A | N/A | N/A |
2021-08-11 | 2021-06 | 0 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2022-11-11 | HC Wainwright & Co. | Upgrade | Buy | |
2021-10-11 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-08-25 | BLATTNER GREGORY JAMES | Director | 12.41K | Stock Award(Grant) |
2022-08-25 | DUDLEY ROBERT FREDERICK | Director | 12.41K | Stock Award(Grant) |
2022-12-13 | HAYES ANTHONY | Chief Executive Officer | 176.68K | Purchase |
2022-08-25 | LEDWICK TIM S | Director | 12.83K | Stock Award(Grant) |
2022-08-25 | LEMIRE PAUL | Director | 12.41K | Stock Award(Grant) |
2022-08-25 | VANDER ZANDEN ROBERT J | Director | 12.70K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-09-29 | Vanguard Group, Inc. (The) | 193.54K | 689.01K | 3.53% |
2022-09-29 | Two Sigma Advisers, LP | 86.70K | 308.65K | 1.58% |
2022-09-29 | Blackrock Inc. | 75.28K | 267.98K | 1.37% |
2022-09-29 | Dimensional Fund Advisors LP | 57.85K | 205.94K | 1.05% |
2022-09-29 | Two Sigma Investments, LP | 53.60K | 190.80K | 0.98% |
2022-09-29 | Geode Capital Management, LLC | 43.41K | 154.54K | 0.79% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-09-29 | Vanguard Total Stock Market Index Fund | 111.01K | 395.21K | 2.02% |
2022-09-29 | Vanguard Extended Market Index Fund | 77.59K | 276.22K | 1.41% |
2022-07-30 | Dimensional ETF Tr-Dimensional U.S. Targeted Value ETF | 25.46K | 90.63K | 0.46% |
2022-10-30 | Fidelity Extended Market Index Fund | 23.58K | 83.94K | 0.43% |
2022-07-30 | DFA U.S. Small Cap Series | 8.87K | 31.58K | 0.16% |
2022-10-30 | Fidelity Total Market Index Fund | 7.42K | 26.41K | 0.14% |
Dividend | Date |
---|---|
0.0389 | 1980-05-12 |
0.0778 | 1979-05-14 |
0.0667 | 1978-05-15 |
Split | Date |
---|---|
1 : 17 | 2022-06-07 |
1113 : 1000 | 2019-10-28 |
1 : 4 | 2019-05-10 |
1 : 19 | 2016-03-04 |
1 : 20 | 2012-09-24 |
1 : 10 | 2011-05-09 |
Fuck Hayes
Uh oh... toilet bowl
Better start buying or this is gonna turn into a real bed shitter...
Because selling is out pacing the buying....
Take your .15 and run
Told you everyone would sell
It’s a wrap. Not breaking above $1.36
Load my house in this
We will see $2 next week
Is AIKI stock a buy?
The best way to assess whether AIKI stock may be a good investment is to look at its target market. The global cancer therapeutics market is on course to exceed $180 billion a year by 2026 from $98.9 billion in 2018. Currently, AIkido Pharma is a low-cost ticket for investors seeking exposure to the lucrative cancer treatment market.
With fierce big pharma competition in the cancer market, it wouldn’t be surprising if AIkido Pharma becomes an acquisition target for industry giants. The company’s modest market capitalization of less than $40 million makes it an easy buyout target. A buyout could open a lucrative exit for AIKI stock investors.
AIkido Pharma Inc. (NASDAQ:AIKI) Shares Look Bullish in 2021
AIkido Pharma Inc. (AIKI)’s beta value is 1.62, and its average true range (ATR) is 0.28. The company’s stock has been forecasted to trade at an average price of $1802.25 over the course of the next 52 weeks, with a low of $1802.25 and a high of $1802.25. Based on these price targets, the low is 136434.09 off current price, whereas the price has to move +136434.09% to reach the yearly target high. Additionally, analysts’ median price of $1802.25 is likely to be welcomed by investors because it represents an increase of +136434.09% from the current levels.
Premarket tomorrow 3$
$2 today
$2 tomorrow
$AIKI bought this one at 1.55 but really scared
$5 this week
Im all in big money coming